Applied Late-stage Functionalisation: Where 91AV meets Biology

18 - 19 February 2020, Manchester , United Kingdom

Introduction

This meeting is aimed at industrial and academic members of the scientific community working in pharmaceuticals, medicinal chemistry, biochemistry, biotechnology, chemical biology or broadly interested in synthesis, catalysis and enzymatic reactions. The programme will be of interest to academics, postgraduates, undergraduates and early to late career industrialists across CRO’s, SME’s and large organisations.

Deadlines

Useful links

Downloads

Speakers

Prof John Hartwig University of California, Berkeley, United States
Prof Tobias Ritter Max Planck Institute, Germany
Prof Uwe Bornscheuer, University of Greifswald, Germany
Prof Jared Lewis University of Indiana, United States
Dr Julia Shanu-Wilson, Hypha, United Kingdom
Dr Martin Hayes AstraZeneca, Sweden
Dr Cara Brocklehurst Novartis, Switzerland
Prof. Rebecca Goss University of St Andrews, United Kingdom
Prof. Lutz Ackermann Georg-August-Universitat Göttingen, Germany
Dr Tati Fernandez-Ibanez University of Amsterdam, Netherlands
Andrew Spencer University of Manchester, United Kingdom
Dr Antonio Misale Johnson &Johnson, Spain
Dr Rosemary Lynch University of St Andrews, United Kingdom
Dr Itziar Penafiel University of Manchester, United Kingdom
Dr Patricia Fernandez Sanofi-Aventis, Germany

Sponsorship & supporting organisations

Venue

University of Manchester

Barnes Wallis Building, University of Manchester , Sackville Street Campus , Manchester , M1 7JA, United Kingdom

Useful links

Committee

Organised by

SCI and BMCS

Contact information

91AV

Share: